Winning World Indices Forecast: ^VIX, ^S&P 500 Perform As Algorithm Predicted

World Indices Package: Notable Performers in the Long and Short Position Amid Volatility

(ShutterStock)

On November 7th 2018, I Know First's top stock predicting algorithm conducted it's 1-Month World Indices Package Forecast. This particular package, which is offered as one of I Know First’s quantitative investment solutions, includes a daily forecast for a total of 20 indices with bullish and bearish signals. This is divided into the top 10 picks for the long position, and top 10 picks for the short position, which are determined by screening our database daily using our advanced algorithm and selecting those with the highest predictability and signal. The two most noteworthy performers of this particular forecast were ^VIX for the long position, and S&P 500 for the short position. The package itself, had an overall average return of 11.28%, in the long position, providing a premium of 15.72% over the SP500’s return of -4.44%. With regards to the short position, the package had an overall average return of 5.79%, providing investors with a premium of 10.23% over S&P500’s return of -4.44%.

Microsoft Stock Forecast: Why On-Premise Office 2019 Is Still Important For Microsoft

motek 1The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

Summary:

  • I will upgrade my Office 2016 to the new 2019 version once Microsoft launches the home version. Office 2019 is currently only available for business users.
  • There are hundreds of millions like me who prefer the offline version of Microsoft’s productivity suite.
  • Microsoft will keep on updating its on premise Office suite because Office 365 is not going to reach 300 million active users anytime soon.
  • As of October 2018, there are only more than 135 million active commercial users of Office 365. This is in spite of its platform-agnostic design.
  • Businesses and ordinary Office users who do not rely too much on online collaboration will find it smarter to just a perpetual license for Office 2019.
  • QCOM stock forecastRead The Full Premium Article

    Subscribe to receive exclusive PREMIUM content Here

I Know First Live forecast evaluation: Extensive Portfolio Evaluation Using Stock Picking Based On S&P 500 Universe

Top S&P 500 Stocks

S&P 500 Evaluation Report

In this report we will evaluate the performance of the forecasts generated by the I Know First AI Algorithm for the S&P 500 universe sent to our customers on a daily basis. We will start with an introduction to our stock picking and benchmarking methods and then apply it to the stocks in the S&P500 universe.

Read The Evaluation Report

GOOGL Forecast: Alphabet Focuses on Future Growth and so Should Investors

 

This article was written by Grant Goldstein, a Financial Analyst at I Know First

   

Highlights:

  • Q1 Expenses Worry Stockholders
  • Google's Upcoming Product Line
  • GOOGL Bullish Forecast
I Know First.  

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Twitter Stock Forecast: Social Media Star Rallies As It Enters S&P 500

  This article was written by Julia Masch, a Financial Analyst at I Know First.




  Highlights

  • Profiting From Profit
  • World Cup and New News Win Engagement
  • Current I Know First Bullish Forecast for TWTR

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning AVXL Stock Forecast: Life Changing Treatment Discoveries and M&A Expectations Add Value to Avanex

“We are looking forward, focusing on executing clinical trials using the inclusion of advanced genomic biomarkers into late-stage CNS precision medicine trials, including our Rett syndrome, Alzheimer’s disease and Parkinson’s disease dementia trials – all indications with high unmet need”

-Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a biopharmaceutical company focused on using genetic medicine to treat neurodegenerative and neurodevelopmental diseases, such as Alzheimer’s disease

Read More

I Know First Review Weekly Algorithmic Performance: April 23, 2017

I Know First Review

On April 23, 2017, our weekly newsletter was sent out to all I Know First subscribers, which can be found here. Below, you may find the I Know First Review, highlighting the algorithm’s performance for this past week. https://iknowfirst.com/i-know-first-review-weekly-algorithmic-performance-april-23-2017